CoChat

Defective Awakening Response to Nocturnal Hypoglycemia in Patients with Type 1 Diabetes Mellitus

Open access

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Nocturnal hypoglycemia frequently occurs in patients with type 1 diabetes mellitus (T1DM). It can be fatal and is believed to promote the development of the hypoglycemia-unawareness syndrome. Whether hypoglycemia normally provokes awakening from sleep in individuals who do not have diabetes, and whether this awakening response is impaired in T1DM patients, is unknown. METHODS AND FINDINGS: We tested two groups of 16 T1DM patients and 16 healthy control participants, respectively, with comparable distributions of gender, age, and body mass index. In one night, a linear fall in plasma glucose to nadir levels of 2.2 mmol/l was induced by infusing insulin over a 1-h period starting as soon as polysomnographic recordings indicated that stage 2 sleep had been reached. In another night (control), euglycemia was maintained. Only one of the 16 T1DM patients, as compared to ten healthy control participants, awakened upon hypoglycemia (p = 0.001). In the control nights, none of the study participants in either of the two groups awakened during the corresponding time. Awakening during hypoglycemia was associated with increased hormonal counterregulation. In all the study participants (from both groups) who woke up, and in five of the study participants who did not awaken (three T1DM patients and two healthy control participants), plasma epinephrine concentration increased with hypoglycemia by at least 100% (p < 0.001). A temporal pattern was revealed such that increases in epinephrine in all participants who awakened started always before polysomnographic signs of wakefulness (mean +/- standard error of the mean: 7.5 +/- 1.6 min). CONCLUSIONS: A fall in plasma glucose to 2.2 mmol/l provokes an awakening response in most healthy control participants, but this response is impaired in T1DM patients. The counterregulatory increase in plasma epinephrine that we observed to precede awakening suggests that awakening forms part of a central nervous system response launched in parallel with hormonal counterregulation. Failure to awaken increases the risk for T1DM patients to suffer prolonged and potentially fatal hypoglycemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.0040069

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Plasma Glucose Concentration during Insulin-Induced Hypoglycemia Mean ± standard error of the mean plasma glucose concentration in 16 control participants (open circles) and in 16 patients with T1DM (filled circles) during insulin-induced hypoglycemia and the subsequent 30 min. Grey horizontal bars indicate intervals of wakefulness (determined by polysomnography) in ten out of 16 healthy individuals awakening upon hypoglycemia. The black horizontal line represents time awake for the only T1DM patient who awoke during hypoglycemia. There were no differences (p > 0.45) between T1DM patients and healthy control participants in glucose infusion rates during the 1-h hypoglycemic interval or between the study participants (from either group) who did and did not wake up.
Figure 1 Plasma Glucose Concentration during Insulin-Induced Hypoglycemia Mean ± standard error of the mean plasma glucose concentration in 16 control participants (open circles) and in 16 patients with T1DM (filled circles) during insulin-induced hypoglycemia and the subsequent 30 min. Grey horizontal bars indicate intervals of wakefulness (determined by polysomnography) in ten out of 16 healthy individuals awakening upon hypoglycemia. The black horizontal line represents time awake for the only T1DM patient who awoke during hypoglycemia. There were no differences (p > 0.45) between T1DM patients and healthy control participants in glucose infusion rates during the 1-h hypoglycemic interval or between the study participants (from either group) who did and did not wake up.CC BY · PubMed Central
Figure 2 Sleep, Plasma Glucose, and Epinephrine Concentrations in Five Individuals during Insulin-Induced Hypoglycemia The panels depict time courses of polysomnographically recorded sleep (black line) in parallel with plasma glucose (green line) and epinephrine (red line) concentrations during the 1-h insulin infusion (0 to 60 min). (A and B) Data from two healthy control participants who displayed the typical awakening response to hypoglycemia. (C) Data from a healthy control participant who did not awaken during hypoglycemia and remained in slow-wave sleep (sleep stages 3 and 4). (D) Data from the only one of the 16 T1DM patients who awakened during hypoglycemia. (E) Data from a typical T1DM patient who did not awaken during hypoglycemia. Note that all study participants who woke up (A, B, and D) show marked rises in epinephrine levels that always start before awakening. Note also that awakening occurred fairly abruptly in most cases (e.g., B and D), and was not preceded by a gradual lightening of sleep. (Left x-axis refers to sleep stages—awake and sleep stages 1 to 4).
Figure 2 Sleep, Plasma Glucose, and Epinephrine Concentrations in Five Individuals during Insulin-Induced Hypoglycemia The panels depict time courses of polysomnographically recorded sleep (black line) in parallel with plasma glucose (green line) and epinephrine (red line) concentrations during the 1-h insulin infusion (0 to 60 min). (A and B) Data from two healthy control participants who displayed the typical awakening response to hypoglycemia. (C) Data from a healthy control participant who did not awaken during hypoglycemia and remained in slow-wave sleep (sleep stages 3 and 4). (D) Data from the only one of the 16 T1DM patients who awakened during hypoglycemia. (E) Data from a typical T1DM patient who did not awaken during hypoglycemia. Note that all study participants who woke up (A, B, and D) show marked rises in epinephrine levels that always start before awakening. Note also that awakening occurred fairly abruptly in most cases (e.g., B and D), and was not preceded by a gradual lightening of sleep. (Left x-axis refers to sleep stages—awake and sleep stages 1 to 4).CC BY · PubMed Central
Figure 3 Counterregulatory Hormonal Responses during Insulin-Induced Hypoglycemia Mean ± standard error of the mean counterregulatory hormone concentrations during insulin-induced hypoglycemia in the 16 healthy control participants (open circles) and in the 16 T1DM patients (filled circles).
Figure 3 Counterregulatory Hormonal Responses during Insulin-Induced Hypoglycemia Mean ± standard error of the mean counterregulatory hormone concentrations during insulin-induced hypoglycemia in the 16 healthy control participants (open circles) and in the 16 T1DM patients (filled circles).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 26

  1. Cryer, 2004, N Engl J Med, 350, 2272
  2. Bendtson, 1991, Diabetologia, 34, 750
  3. Hoi-Hansen, 2005, Diabet Med, 22, 858
  4. Boland, 2001, Diabetes Care, 24, 1858
  5. Chico, 2003, Diabetes Care, 26, 1153
  6. Caduff, 1989, Schweiz Med Wochenschr, 119, 9
  7. Bendtson, 1988, Acta Med Scand, 223, 543
  8. Gale, 1979, Lancet, 1, 1049
  9. Pramming, 1985, Br Med J, 291, 376
  10. Veneman, 1993, Diabetes, 42, 1233
  11. Fanelli, 1998, Diabetes, 47, 1920
  12. Gerich, 1991, Endocr Rev, 12, 356
  13. Sovik, 1999, Diabetes Care, 22, B40
  14. Jones, 1998, N Engl J Med, 338, 1657
  15. Gais, 2003, Sleep, 26, 55
  16. Pillar, 2003, J Pediatr, 142, 163
  17. Matyka, 2000, J Pediatr, 137, 233
  18. Bendtson, 1992, Sleep, 15, 74
  19. Davis, 1997, Diabetes Care, 20, 22
  20. Gade, 1994, Methods Inf Med, 33, 153
  21. Banarer, 2003, Diabetes, 52, 1195
  22. Sturis, 1995, J Clin Invest, 95, 1464
  23. Kern, 1996, J Clin Endocrinol Metab, 81, 1541
  24. Dodt, 1997, Hypertension, 30, 71
  25. Pace-Schott, 2002, Nat Rev Neurosci, 3, 591
  26. Born, 1999, Nature, 397, 29

Cited by

See all 102

Metadata

Authors
Schultes, B., Jauch-Chara, K., Gais, S., Hallschmid, M., Reiprich, E., Kern, W., Oltmanns, K. M., Peters, A., Fehm, H. L., & Born, J.
Affiliations
University of Lübeck (DE)
Corresponding author
Schultes, Bernd
Venue
PLoS Medicine
Published
2007-02-27
Volume
4
Issue
2
Pages
e69
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2016851323
Cited by
100
References
34
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 8 · 2014: 6 · 2013: 6 · 2012: 3
FWCI
5.12
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Deutsche Forschungsgemeinschaft (SFB654)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
Keywords
nocturnal hypoglycemia, type 1 diabetes, hypoglycemia unawareness, sleep, epinephrine, counterregulatory hormones, hypoglycemic coma, insulin-induced hypoglycemia
MeSH terms
Adrenocorticotropic Hormone, Adult, Blood Glucose, Circadian Rhythm, Diabetes Mellitus, Type 1, Epinephrine, Female, Humans, Hydrocortisone, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Norepinephrine, Sleep, Wakefulness, Single-Blind Method, Polysomnography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defective Awakening Response to Nocturnal Hypoglycemia in Patients with Type 1 Diabetes Mellitus. https://app.cochat.ai/papers/10.1371/journal.pmed.0040069
The paper
Schultes, B., Jauch-Chara, K., Gais, S., Hallschmid, M., Reiprich, E., Kern, W., Oltmanns, K. M., Peters, A., Fehm, H. L., & Born, J. (2007). Defective Awakening Response to Nocturnal Hypoglycemia in Patients with Type 1 Diabetes Mellitus. PLoS Medicine. https://doi.org/10.1371/journal.pmed.0040069

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.